SAPIRSTEIN JAMES — SEC insider filings

SEC reporting owner CIK 1559509. 24 insider filings on record with FilingPulse; latest filed 2026-09-17.

Transaction summary — filings shown

Covers all 24 filings on record, filed 2021-03-11 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Entero Therapeutics, Inc. (ENTO)Chairman and CEO, Director11—7 legs · 12,976 sh · $26,4986
RENOVARO INC. (RENB)Director4——4
Onconetix, Inc. (ONCO)Director3——3
ZyVersa Therapeutics, Inc. (ZVSA)Director2——2
Cocrystal Pharma, Inc. (COCP)Chief Executive Officer1——1
Inmune Bio, Inc. (INMB)Director2——1
MARIZYME INC (MRZM)Interim CEO, Director1——1

Insider filings — SAPIRSTEIN JAMES

FiledFormIssuerReported transactionsSource
2026-09-174Inmune Bio, Inc. (INMB)Grant/award (A): 100,000 (derivative) @ $0EDGAR
2026-09-163Inmune Bio, Inc. (INMB)Holdings only — no transactions reportedEDGAR
2026-06-034Cocrystal Pharma, Inc. (COCP)Grant/award (A): 235,000 (derivative) @ $0EDGAR
2025-07-154ZyVersa Therapeutics, Inc. (ZVSA)Grant/award (A): 11,066 (derivative) @ $0EDGAR
2024-09-304Onconetix, Inc. (ONCO)Grant/award (A): 3,318 @ $0EDGAR
2024-07-184ZyVersa Therapeutics, Inc. (ZVSA)Grant/award (A): 132 (derivative) @ $0EDGAR
2024-07-034Entero Therapeutics, Inc. (ENTO)Sale (S): 1,289 @ $1.07EDGAR
2024-06-274RENOVARO INC. (RENB)Grant/award (A): 48,137 (derivative) @ $0EDGAR
2024-04-034First Wave BioPharma, Inc. (FWBI)Sale (S): 174 @ $4.23EDGAR
2024-03-194RENOVARO INC. (RENB)Grant/award (A): 28,196 (derivative) @ $0EDGAR
2024-03-194First Wave BioPharma, Inc. (FWBI)Sale (S): 1,887 @ $4.96EDGAR
2024-01-174First Wave BioPharma, Inc. (FWBI)Sale (S): 166 @ $4.20EDGAR
2024-01-034First Wave BioPharma, Inc. (FWBI)Grant/award (A): 17,660 @ $0 · Grant/award (A): 20,000 @ $0EDGAR
2023-10-064First Wave BioPharma, Inc. (FWBI)Sale (S): 2,764 @ $0.29EDGAR
2023-07-054First Wave BioPharma, Inc. (FWBI)Sale (S): 3,349 @ $1.54EDGAR
2023-06-014Blue Water Biotech, Inc. (BWV)Grant/award (A): 6,360 @ $0EDGAR
2023-04-054First Wave BioPharma, Inc. (FWBI)Sale (S): 3,347 @ $2.50EDGAR
2023-04-044Enochian Biosciences Inc (ENOB)Grant/award (A): 64,655 (derivative) @ $0EDGAR
2023-01-054First Wave BioPharma, Inc. (FWBI)Grant/award (A): 300,000 @ $0EDGAR
2022-05-274Blue Water Vaccines Inc. (BWV)Grant/award (A): 50,575 (derivative) @ $0EDGAR
2022-01-034First Wave BioPharma, Inc. (FWBI)Grant/award (A): 150,000 (derivative) @ $0EDGAR
2021-07-024AzurRx BioPharma, Inc. (AZRX)Other (J): 900,000 (derivative) @ $0 · Grant/award (A): 900,000 (derivative) @ $0EDGAR
2021-03-234MARIZYME INC (MRZM)Grant/award (A): 125,000 (derivative) @ $1.25EDGAR
2021-03-114Enochian Biosciences Inc (ENOB)Grant/award (A): 19,894 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-03-08 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1559509 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs